Efficacy of plasma exchange in the therapy of recurrent pregnancy-associated atypical hemolytic-uremic syndrome

Kirsanova T.V., Fedorova T.A., Gurbanova S.R., Pyregov A.V., Vinogradova M.A.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Background. Pregnancy-associated atypical hemolytic-uremic syndrome (aHUS) is characterized by an aggressive avalanche-like course and an extremely poor prognosis with fulminant thrombotic microangiopathy (TMA), whereas targeted therapy with a complement-blocking drug is always impossible in the first 24 hours. There are very few cases of recurrent pregnancy-associated aHUS in the modern literature; in this connection it is important to display the management of patients with the second disease episode that has developed during pregnancy. In the era of eculizumab, the role of plasma exchange in verified aHUS is becoming increasingly limited. Just the same, when eculizumab is not available, plasma exchange remains the only treatment option.
Case report. The paper presents the experience in successfully treating two consecutive pregnancy-associated aHUS episodes manifested after delivery in one patient, by using only plasma exchange, which showed a favorable outcome, including complete recovery of renal function.
Conclusion. Different types of TMA in pregnancy are fulminant and represent a life-threatening condition for the mother. In this condition, the most urgent issue is the timely initiation of appropriate therapy. The presented observation of two aHUS episodes demonstrates difficulties in choosing a treatment policy and in making a rapid differential diagnosis, even when there is only one episode of TMA in the history. The discussion lists the recommended treatment regimens, as well as the possibility of a favorable outcome with timely initiation of plasma therapy

Keywords

plasma exchange
thrombotic microangiopathy
atypical hemolytic-uremic syndrome (a-HUS)
pregnancy

References

  1. Fakhouri F., Scully M., Provôt F., Blasco M., Coppo P., Noris M. et al. Management of thrombotic microangiopathy in pregnancy and postpartum: Report From an International Working Group. Blood. 2020; 136(19): 2103-17. https://dx.doi.org/10.1182/blood.2020005221.
  2. Gupta M., Govindappagari S., Burwick R.M. Pregnancy-associated atypical hemolytic uremic syndrome: A systematic review. Obstet. Gynecol. 2020; 135(1): 46-58. https://dx.doi.org/10.1097/AOG.0000000000003554.
  3. Scully M., Hunt B.J., Benjamin S., Liesner R., Rose P., Peyvandi F. et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br. J. Haematol. 2012; 158(3): 323-35. https://dx.doi.org/10.1111/j.1365-2141.2012.09167.x.
  4. Birkhoelzer S., Belcher A., Peet H. Diagnostic dilemma: Severe thrombotic microangiopathy in pregnancy. J. Intensive Care Soc. 2017; 18(4): 348-51. https://dx.doi.org/10.1177/1751143717715969.
  5. Appel G.B. Thrombotic microangiopathies: Similar presentations, different therapies. Cleve Clin. J. Med. 2017; 84(2): 114-30. https://dx.doi.org/10.3949/ccjm.84gr.17001.
  6. Elayoubi J., Donthireddy K., Nemakayala D.R. Microangiopathies in pregnancy. BMJ Case Rep. 2018; 2018: bcr-2017-221648. https://dx.doi.org/10.1136/bcr-2017-221648.
  7. Legendre C.M., Licht C., Muus P., Greenbaum L.A., Babu S., Bedrosian C. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2013; 368(23): 2169-81. https://dx.doi.org/10.1056/NEJMoa1208981.
  8. Padmanabhan A., Connelly-Smith L., Aqui N., Balogun R.A., Klingel R., Meyer E. et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J. Clin. Apher. 2019; 34(3): 171-354. https://dx.doi.org/10.1002/jca.21705.
  9. Schwartz J., Padmanabhan A., Aqui N., Balogun R.A., Connelly-Smith L., Delaney M. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The Seventh Special Issue. J. Clin. Apher. 2016; 31(3): 149-62. https://dx.doi.org/10.1002/jca.21470.
  10. Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Rabasco C., Espinosa M. et al. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Kidney Int. 2018; 93(2): 450-9. https://dx.doi.org/10.1016/j.kint.2017.06.022.
  11. Eddy A.A., Geary D.F., Balfe J.W., Clark W.F., Baumal R. Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy. Pediatr. Nephrol. 1989; 3(4): 420-3. https://dx.doi.org/10.1007/bf00850219.
  12. Filler G., Radhakrishnan S., Strain L., Hill A., Knoll G., Goodship T.H. Challenges in the management of infantile factor H associated hemolytic uremic syndrome. Pediatr. Nephrol. 2004; 19(8): 908-11. https://dx.doi.org/10.1007/s00467-004-1526-9.
  13. Laurence J., Haller H., Mannucci P.M. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clin. Adv. Hematol. Oncol. 2016; 14(Suppl. 11): 2-15.
  14. Hou R., Tian W., Qiao R., Zhang J. Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura. J. Clin. Apher. 2020; 35(3): 154-62. https://dx.doi.org/10.1002/jca.21771.
  15. Кирсанова Т.В., Федорова Т.А., Гурбанова С.Р., Балакирева А.И., Рогачевский О.В., Виноградова М.А., Завьялова И.В. Ургентный плазмообмен при лечении тромботической микроангиопатии в послеродовом периоде у женщин. Анестезиология и реаниматология. 2020; 5: 85-91. [Kirsanova T.V., Fedorova T.A., Gurbanova S.R., Balakireva A.I., Rogachevsky O.V., Vinogradova M.A., Zavyalova I.V. Urgent plasma exchange in the treatment of post-partum thrombotic microangiopathy in women. Anesthesiology and resuscitation. 2020; 5: 85-91. (in Russian)]. https://dx.doi.org/10.17116/anaesthesiology202005185.
  16. Claes K., Massart A., Collard L., Weeker L., Goffin E., Pochet Jean-M. et al. Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome. Acta Clin. Belg. 2018; 73(1): 80-9. https://dx.doi.org/10.1080/17843286.2017.1345185.
  17. Gupta M., Feinberg B.B., Burwick R.M. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy Hypertens. 2018; 12: 29-34. https://dx.doi.org/10.1016/j.preghy.2018.02.007.

Received 02.12.2020

Accepted 29.04.2021

About the Authors

Tatyana V. Kirsanova, PhD, Senior Researcher of the Department of Transfusiology and Extracorporeal Hemocorrection, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(926)248-45-60. E-mail: a_tatya@mail.ru. ORCID: 0000-0002-6125-590X.
117997, Russia, Moscow, Academician Oparin str., 4.
Tatiana A. Fedorova, MD, professor, Head of the Department of Transfusiology and Extracorporeal Hemocorrection, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. E-mail: tfedorova1@mail.ru. ORCID: 0000-0001-6883-4456.
117997, Russia, Moscow, Academician Oparin str., 4.
Samira R. Gurbanova, PhD, researcher of the Department of Extracorporal Methods of Treatment and Detoxification, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. E-mail: gursam81@mail.ru. ORCID: 0000-0003-3491-1868.
117997, Russia, Moscow, Academician Oparin str., 4.
Maria A. Vinogradova, PhD, Head of Department of Reproductive Hematology and Clinical Hemostasiology, Academician V.I. Kulakov National Medical Research
Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. E-mail: mary-grape@yandex.ru. ORCID: 0000-0001-9827-1922.
117997, Russia, Moscow, Academician Oparin str., 4.
Aleksey V. Pyregov, MD, Head of the Department of Anesthesiology-Resuscitation, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. E-mail: a_pyregov@oparina4.ru. ORCID: 0000-0001-8382-9671. 117997, Russia, Moscow, Academician Oparin str., 4.

For citation: Kirsanova T.V., Fedorova T.A., Gurbanova S.R., Pyregov A.V., Vinogradova M.A. Efficacy of plasma exchange in the therapy of recurrent
pregnancy-associated atypical hemolytic-uremic syndrome.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 6: 186-191 (in Russian)
https://dx.doi.org/10.18565/aig.2021.6.186-191

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.